GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
304.87B
WLGAX
Price
$36.79
Change
+$0.38 (+1.04%)
Updated
Jun 6 closing price
Net Assets
7.87B
Interact to see
Advertisement

GAFFX vs WLGAX

Header iconGAFFX vs WLGAX Comparison
Open Charts GAFFX vs WLGAXBanner chart's image
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets304.87B
Macquarie Large Cap Growth Fund A
Price$36.79
Change+$0.38 (+1.04%)
VolumeN/A
Net Assets7.87B
GAFFX vs WLGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. WLGAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and WLGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. WLGAX (7.87B). GAFFX pays higher dividends than WLGAX: GAFFX (0.65) vs WLGAX (0.00). GAFFX was incepted earlier than WLGAX: GAFFX (8 years) vs WLGAX (25 years). WLGAX (0.99) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. WLGAX (9.00). WLGAX has a lower initial minimum investment than GAFFX: WLGAX (1000) vs GAFFX (1000000). GAFFX (9.74) and WLGAX (9.53) have marching annual gain over last year. GAFFX return over 5 years is better than : 47.05 vs. WLGAX (43.43).
GAFFXWLGAXGAFFX / WLGAX
Total Expense Ratio0.300.8934%
Annual Report Gross Expense Ratio0.300.9930%
Fund Existence8 years25 years-
Gain YTD5.6401.238455%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets305B7.87B3,874%
Annual Yield % from dividends0.650.00-
Returns for 1 year9.749.53102%
Returns for 3 years38.5635.11110%
Returns for 5 years47.0543.43108%
Returns for 10 yearsN/A93.22-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc